Early notice101240-2026
NP47827 Multiple Sclerosis Medicines
BuyerThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Expected to be publishedJan 2027The buyer’s own estimate; it can move.
- Published26 Oct 2026
- Estimated value
- £30,403,887, excluding VAT
- Contract term
- Not stated in the notice
- Lots
- 3 lotsGlatiramer acetate, Interferon beta-1a and NatalizumabCladribine tabletsFingolimod, Teriflunomide and Dimethyl Fumarate
- Categories
- 33600000Pharmaceutical products
- Regions
- Scotland
The buyer’s description
“The Authority seeks to establish a Framework Agreement covering Multiple Sclerosis medicines. The range of medicines under consideration for inclusion in the Framework Agreement are listed below (subject to removal or replacement due to a continually shifting litigation landscape): Glatiramer acetate Interferon beta-1a Teriflunomide Dimethyl fumarate Fingolimod Natalizumab Cladribine”
Could you win this?
Find your company to see how this tender matches your past work.